Baker & McKenzie advised Air Liquide on acquisition of majority stake in Optimal Medical Therapies
Baker & McKenzie advised Air Liquide on the acquisition of a majority stake in the Optimal Medical Therapies Group (OMT), a leading German player in home healthcare services for patients in Germany suffering from chronic illnesses requiring infusion therapy. The transaction was closed at the beginning of 2015.
With this transaction Air Liquide has strengthened the development of its home healthcare activity in Germany. Air Liquide is a leading provider of infusion therapy in France and Northern Europe.